Search results - 14 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
(2023) Keywords: Alpha COVID-19 Delta Vaccine effectiveness Health Topics: Acute respiratory tract infection Acute luchtweginfectie Infection respiratoire aiguë Service: Maladies virales Virale ziekten ...
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.
Publication Type: Peer reviewed scientific article Authors: Meyer Sauteur, Patrick M; Beeton, Michael L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Keywords: COVID-19 Humans Pandemics Population Surveillance Respiratory Syncytial Virus Infections Respiratory Syncytial Virus, Human SARS-CoV-2 Seasons Abstract: BACKGROUND: The emergence of the Severe Acute ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
SARS-CoV-2 in hospitalised severe acute respiratory illness (SARI) patients ≥ 20 years, combining data from these networks during Alpha (March-June)- and Delta (June-December)-dominant periods, ...
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
Topics: Acute respiratory tract infection Acute luchtweginfectie Infection respiratoire aiguë Service: Épidémiologie des maladies infectieuses Epidemiologie van infectieziekten Epidemiology of infectious ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Topics: Acute respiratory tract infection Acute luchtweginfectie Infection respiratoire aiguë Service: Maladies virales Virale ziekten Viral diseases Épidémiologie des maladies infectieuses Epidemiologie ...
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
Acute luchtweginfectie Infection respiratoire aiguë Service: Épidémiologie des maladies infectieuses Epidemiologie van infectieziekten Epidemiology of infectious diseases Manuscript versions: DOI: ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
elucidate the epidemiology and burden of disease of seasonal hCoVs OC43, NL63, and 229E in patients in primary care and hospitals in Belgium between 2015 and 2020. Methods: We retrospectively analysed data ...
Evaluation of the added value of viral genomic information for predicting severity of influenza infection
Devleesschauwer; Isabelle Thomas; Kevin Vanneste; Nancy Roosens; Herman Van Oyen Source: BMC Infectious Diseases, Volume 21, Issue 1 (2021) Health Topics: Flu Griep Grippe Acute respiratory tract infection Acute ...